Glitaris 30 Tablet

Glitaris 30 Tablet is a prescription diabetes medicine that contains pioglitazone 30 mg in each tablet. It belongs to the thiazolidinedione (TZD) class and is used to help improve blood sugar control in adults with type 2 diabetes. Glitaris 30 Tablet is not insulin and is not used for type 1 diabetes or diabetic ketoacidosis. It is usually used along with diet, exercise, and sometimes other diabetes medicines.

How it works: Pioglitazone helps the body respond better to insulin, so glucose can move from the blood into the cells more easily. As a tablet, Glitaris 30 Tablet is taken by mouth and works gradually to lower blood sugar over time rather than giving a quick, immediate effect.

Glitaris 30 Tablet is a higher-strength pioglitazone tablet compared with Glitaris 15 Tablet and Glitaris 7.5 Tablet. Doctors may choose Glitaris 30 Tablet when a lower strength is not enough, or when a patient has already been assessed and needs a stronger daily dose. Because it is a stronger tablet, it is meant for people whose prescriber has decided this dose is appropriate rather than for starting treatment on your own.

• Type 2 diabetes blood sugar control
• Add-on treatment with diet and exercise
• Use with other antidiabetic medicines when prescribed
• Improving insulin sensitivity in adults

• Swallow Glitaris 30 Tablet whole with water.
• Take it at the same time each day if your doctor has prescribed daily use.
• It can be taken with or without food.
• Do not crush, split, or chew the tablet unless your pharmacist or doctor tells you to.
• Keep following your diabetes meal plan and exercise routine while taking it.
• Check your blood sugar as directed, because the dose is adjusted based on response.

Each Glitaris 30 Tablet provides pioglitazone 30 mg. Depending on your blood sugar response and other medicines, a doctor may prescribe it once daily, and the exact schedule is decided by the prescriber. The maximum usual daily dose of pioglitazone is 45 mg per day, so Glitaris 30 Tablet should not be combined into a higher total dose unless your doctor specifically directs it.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Pioglitazone may include:

• Swelling of the hands, ankles, or feet
• Weight gain
• Headache
• Muscle aches
• Cold-like symptoms
• Sore throat
• More noticeable fluid retention at this 30 mg strength

• Use caution if you have heart failure or a history of fluid retention, because pioglitazone can worsen swelling.
• Tell your doctor if you have liver disease or a history of abnormal liver tests before using Glitaris 30 Tablet.
• This 30 mg strength may cause more swelling or weight gain than lower strengths in some people.
• Avoid alcohol excess, since it can make blood sugar harder to control and may add liver risk.
• Your blood sugar can go too low if Glitaris 30 Tablet is used with insulin or a sulfonylurea.
• Tell your doctor if you have a history of bladder cancer, blood in the urine, or frequent urinary problems.
• Be careful when driving or operating machinery if you feel dizzy or weak from low blood sugar or other medicines.

• Insulin, which can increase the risk of fluid retention and low blood sugar when combined with pioglitazone
• Sulfonylureas such as glimepiride or glipizide, which can raise the risk of hypoglycemia
• Gemfibrozil, which may increase pioglitazone levels
• Rifampin, which may reduce pioglitazone levels
• Alcohol, which can complicate blood sugar control and liver safety

Store Glitaris 30 Tablet in its original strip or box at room temperature, away from moisture, heat, and direct light.